Established in 2014, 4P-Pharma is a clinical stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class …

Dec 14, 2022 · We leverage assets with a short time to market, strong IP position, and regulatory opportunities (emergency use or conditional marketing authorizations) in blue-ocean markets. …

4P-Pharma pipeline covers an extensive spectrum of therapeutic areas, encompassing chronic and autoimmune diseases, respiratory and infectious diseases, preventive therapies, and …

May 26, 2023 · 4P-Pharma fera partie de la délégation française au BIO US 2023 qui aura lieu à Boston du 5 au 8 juin. Roselina Lam, notre Business Development and licensing-in Manager …

Nov 5, 2024 · By joining France Deeptech, 4P-Pharma strengthens its commitment to innovation in healthcare and continues its mission to deliver new and ambitious therapeutic solutions, …

Apr 23, 2024 · 4P-Pharma Reveals Its Brand New Identity This new identity represents a significant milestone in our company’s journey, from a biotech start-up to a clinical-stage …

Feb 29, 2024 · 4P-Pharma supports World Rare Disease Day On World Rare Disease Day, our team stands together to show support for those who suffer from rare diseases. For the past …

Any reproduction, even partial, of any content of our website is strictly prohibited without the express authorization of 4P-Pharma. The logo and domain name “www.4p-pharma.com” are …

We are thrilled to announce Jérôme Vailland’s appointment as 4P-Pharma’s new Chief Financial Officer. Jérôme Vailland built a solid career with significant contributions at Ernst & Young …

Nov 24, 2022 · 4P-Pharma is pleased to share with you a series of three videos produced in collaboration with Entreprendre magazine in order to highlight innovative biotechnology …